These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8080691)
1. Pharmacokinetics and cancer chemotherapy. Workman P; Graham MA Eur J Cancer; 1994; 30A(5):706-10. PubMed ID: 8080691 [No Abstract] [Full Text] [Related]
2. Recent advances in cancer chemotherapy: current strategies, pharmacokinetics, and pharmacogenomics. Nishiyama M; Eguchi H Adv Drug Deliv Rev; 2009 May; 61(5):367-8. PubMed ID: 19154764 [No Abstract] [Full Text] [Related]
3. The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicity. Boddy AV; Idle JR Cancer Surv; 1993; 17():79-104. PubMed ID: 8137354 [TBL] [Abstract][Full Text] [Related]
4. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics. Deeken JF; Figg WD; Bates SE; Sparreboom A Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598 [TBL] [Abstract][Full Text] [Related]
5. New approaches in preclinical and clinical pharmacokinetics. Graham MA; Kaye SB Cancer Surv; 1993; 17():27-49. PubMed ID: 8137345 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetically guided dose-escalation (PGDE) strategy]. Saeki T Gan To Kagaku Ryoho; 2000 Jul; 27(7):1069-74. PubMed ID: 10925698 [TBL] [Abstract][Full Text] [Related]
7. New techniques in the pharmacokinetic analysis of cancer drugs. IV. Positron emission tomography. Tilsley DW; Harte RJ; Jones T; Brady F; Luthra SK; Brown G; Price PM Cancer Surv; 1993; 17():425-42. PubMed ID: 8137352 [TBL] [Abstract][Full Text] [Related]
9. Not only tumor but also therapy heterogeneity. Garattini S; Fuso Nerini I; D'Incalci M Ann Oncol; 2018 Jan; 29(1):13-19. PubMed ID: 29045538 [No Abstract] [Full Text] [Related]
11. Pharmacogenetics in cancer etiology and chemotherapy. Boddy AV; Ratain MJ Clin Cancer Res; 1997 Jul; 3(7):1025-30. PubMed ID: 9815780 [No Abstract] [Full Text] [Related]
12. Pharmacogenetics for individualized cancer chemotherapy. Efferth T; Volm M Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients. Perez-Ruixo JJ; Piotrovskij V; Zhang S; Hayes S; De Porre P; Zannikos P Br J Clin Pharmacol; 2006 Jul; 62(1):81-96. PubMed ID: 16842381 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy. Marsh S; Liu G Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and cancer: successes, failures and future prospects. Workman P Cancer Surv; 1993; 17():1-26. PubMed ID: 8137337 [TBL] [Abstract][Full Text] [Related]
16. Early phase cancer clinical trials: design, ethics and future directions. Coupe N; Gupta A; Lord SR Br J Hosp Med (Lond); 2015 Jul; 76(7):409-13. PubMed ID: 26140560 [TBL] [Abstract][Full Text] [Related]
17. Germline pharmacogenetics of paclitaxel for cancer treatment. Hertz DL Pharmacogenomics; 2013 Jul; 14(9):1065-84. PubMed ID: 23837481 [TBL] [Abstract][Full Text] [Related]